Success Rates in Development Stage Dealmaking
Executive Summary
Just how frequently do deals fail? To begin to answer the question, we looked back at 41 significant clinical-stage deals-those valued at over $20 million--signed by Big Pharma or Big Biotech in 2002 and 2003 to see what percentage of them is still ongoing.